1. Margins in DCIS: Does Residual Disease Provide an Answer?

   • Monica Morrow
   • Kimberly J. Van Zee

   Breast Oncology 10 May 2016 Pages: 3423 - 3425

2. Sentinel Lymph Node Biopsy in Breast Cancer Surgery

   • J. Michael Dixon

   Breast Oncology 22 July 2016 Pages: 3426 - 3428

3. Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy for Patients with Axillary Metastases: Can We Avoid the Unavoidable?

   • Theresa Schwartz
   • Carla Fisher

   Breast Oncology 26 July 2016 Pages: 3429 - 3431

4. Limiting Axillary Surgery for Patients with Initial Biopsy-Proven Axillary Metastases After Preoperative Chemotherapy: To Clip or Not to Clip?

   • Henry M. Kuerer
   • Kelly K. Hunt

   Breast Oncology 28 July 2016 Pages: 3432 - 3434

5. Surgical Breast Specialists 2.0: Rethinking the Future of Breast Fellowship Training

   • Peter D. Beitsch
   • Pat Whitworth

   Breast Oncology 22 June 2016 Pages: 3435 - 3437

6. What Does the Future Hold for Surgical Breast Specialists? Implications for Breast Fellowship Training

   • Scott H. Kurtzman

   Breast Oncology 24 June 2016 Pages: 3438 - 3439

7. Guidelines for the Treatment of Recurrent Retroperitoneal Sarcoma: Are we Trying to Fit a Square Peg into a Round Hole?

   • Barry Feig
   • Robert Benjamin

   Bone and Soft Tissue Sarcomas 22 June 2016 Pages: 3440 - 3443

   

8. Association of Distance Traveled for Surgery with Short- and Long-Term Cancer Outcomes

   • Nabil Wasif
   • Yu-Hui Chang
   • David Etzioni

   Healthcare Policy and Outcomes 28 April 2016 Pages: 3444 - 3452

   

9. Should New “No Ink On Tumor” Lumpectomy Margin Guidelines be Applied to Ductal Carcinoma In Situ (DCIS)? A Retrospective Review Using Shaved Cavity Margins

   • Andrea L. Merrill
   • Rong Tang
   • Barbara L. Smith

   Breast Oncology 20 May 2016 Pages: 3453 - 3458

10. Troubleshooting Sentinel Lymph Node Biopsy in Breast Cancer Surgery

    • Ted A. James
    • Alex R. Coffman
    • Seth P. Harlow

    Breast Oncology 21 July 2016 Pages: 3459 - 3466

    

11. How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study

    • Anita Mamtani
    • Andrea V. Barrio
    • Monica Morrow

    Breast Oncology 09 May 2016 Pages: 3467 - 3474

    

12. How Often Is Treatment Effect Identified in Axillary Nodes with a Pathologic Complete Response After Neoadjuvant Chemotherapy?

    • Andrea V. Barrio
    • Anita Mamtani
    • Monica Morrow

    Breast Oncology 28 July 2016 Pages: 3475 - 3480

    

13. Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases

    • Anita Mamtani
    • Sujata Patil
    • Monica Morrow

    Breast Oncology 11 May 2016 Pages: 3481 - 3486

14. Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?

    • Melissa Pilewskie
    • Michelle Stempel
    • Monica Morrow

    Breast Oncology 12 May 2016 Pages: 3487 - 3493

    

15. A Picture is Worth a Thousand Words: Intraoperative Photography as a Quality Metric for Axillary Dissection

    • Brittany L. Murphy
    • Judy C. Boughey
    • James W. Jakub

    Breast Oncology 19 May 2016 Pages: 3494 - 3500

    

16. Nomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast Cancer

    • Jose Vila
    • Elizabeth A. Mittendorf
    • Abigail S. Caudle

    Breast Oncology 23 May 2016 Pages: 3501 - 3509

    

17. Neoadjuvant Systemic Therapy for Breast Cancer: Factors Influencing Surgeons’ Referrals

    • Eleftherios Mamounas
    • Christine Poulos
    • Vincent Antao

    Breast Oncology Open access 09 June 2016 Pages: 3510 - 3517

    

18. How Beneficial is Follow-Up Mammography in Elderly Breast Cancer Survivors?

    • Kristen P. Massimino
    • Maxine S. Jochelson
    • Monica Morrow

    Breast Oncology 15 June 2016 Pages: 3518 - 3523

19. Coexistent Loss of the Expressions of BRCA1 and p53 Predicts Poor Prognosis in Triple-Negative Breast Cancer

    • Min Chong Kim
    • Jung Eun Choi
    • Young Kyung Bae

    Breast Oncology 08 June 2016 Pages: 3524 - 3530

    

20. Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group

    • Trans-Atlantic RPS Working Group

    Bone and Soft Tissue Sarcomas 01 August 2016 Pages: 3531 - 3540

    

21. Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children’s Oncology Group

    • Najat C. Daw
    • Nadia N. Laack
    • R. Lor Randall

    Bone and Soft Tissue Sarcomas 23 May 2016 Pages: 3541 - 3547

    

22. National Evaluation of Hospital Performance on the New Commission on Cancer Melanoma Quality Measures

    • Christina A. Minami
    • Jeffrey D. Wayne
    • Karl Y. Bilimoria

    Melanomas 08 June 2016 Pages: 3548 - 3557

    

23. LYMPHA Technique to Prevent Secondary Lower Limb Lymphedema

    • Francesco Boccardo
    • Mario Valenzano
    • Corradino Campisi

    Melanomas 24 May 2016 Pages: 3558 - 3563

    

24. Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System

    • Kelly L. Harms
    • Mark A. Healy
    • Sandra L. Wong

    Medical Oncology 19 May 2016 Pages: 3564 - 3571

    

25. Radiation Therapy is Associated with Improved Outcomes in Merkel Cell Carcinoma

    • Tobin Strom
    • Michael Carr
    • Jimmy J. Caudell

    Radiation Oncology 01 June 2016 Pages: 3572 - 3578

    

26. Clinical Impact of Intraoperative Cytological Assessment of Bone Resection Margins in Patients with Head and Neck Carcinoma

    • Markus Nieberler
    • Patrick Häußler
    • Klaus-Dietrich Wolff

    Head and Neck Oncology 25 March 2016 Pages: 3579 - 3586

    

27. Incidence and Risk Factors for Occult Level 3 Lymph Node Metastases in Papillary Thyroid Cancer

    • Sheila Fraser
    • Nisar Zaidi
    • Stan B. Sidhu

    Head and Neck Oncology 17 May 2016 Pages: 3587 - 3592

    

28. Treatment Interval between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer Patients: A Population-Based Study

    • A. J. M. Rombouts
    • N. Hugen
    • J. H. W. de Wilt

    Colorectal Cancer Open access 01 June 2016 Pages: 3593 - 3601

    

29. Prognostic Impact of Palliative Primary Tumor Resection for Unresectable Stage 4 Colorectal Cancer: Using a Propensity Score Analysis

    • Dai Shida
    • Tetsuya Hamaguchi
    • Yukihide Kanemitsu

    Colorectal Cancer 08 June 2016 Pages: 3602 - 3608

    

30. The Use of Re-irradiation in Locally Recurrent, Non-metastatic Rectal Cancer

    • Matthew Susko
    • Jason Lee
    • Manisha Palta

    Radiation Oncology 11 May 2016 Pages: 3609 - 3615

    

31. Is Survival for Patients with Resectable Lung Metastatic Colorectal Cancer Comparable to Those with Resectable Liver Disease? Results from the South Australian Metastatic Colorectal Registry

    • Dainik Patel
    • Amanda R. Townsend
    • Timothy J. Price

    Thoracic Oncology 01 June 2016 Pages: 3616 - 3622

    

32. Value of Percutaneous Radiologic Gastrostomy for Patients with Advanced Esophageal Cancer

    • Keitaro Sofue
    • Yoshito Takeuchi
    • Yasuaki Arai

    Thoracic Oncology 17 May 2016 Pages: 3623 - 3631

    

33. Impact of Neoadjuvant Chemoradiation on Short-Term Outcomes for Esophageal Squamous Cell Carcinoma Patients: A Meta-analysis

    • Suun Sathornviriyapong
    • Akihisa Matsuda
    • Eiji Uchida

    Thoracic Oncology 08 June 2016 Pages: 3632 - 3640

    

34. Lobectomy is a more Cost-Effective Option than Total Thyroidectomy for 1 to 4 cm Papillary Thyroid Carcinoma that do not Possess Clinically Recognizable High-Risk Features

    • Brian Hung-Hin Lang
    • Carlos K. H. Wong

    Endocrine Tumors 24 May 2016 Pages: 3641 - 3652

    

35. Can We Predict the Lateral Compartment Lymph Node Involvement in RET-Negative Patients with Medullary Thyroid Carcinoma?

    • Marie-Maelle Chandeze
    • Severine Noullet
    • Fabrice Menegaux

    Endocrine Tumors 06 June 2016 Pages: 3653 - 3659

    

36. A Population-Based Analysis of Three Treatment Modalities for Malignant Obstruction of the Proximal Colon: Acute Resection Versus Stent or Stoma as a Bridge to Surgery

    • F. J. Amelung
    • E. C. J. Consten
    • P. J. Tanis

    Gastrointestinal Oncology Open access 24 May 2016 Pages: 3660 - 3668

    

37. Low Preoperative Prognostic Nutritional Index Predicts Poor Survival Post-gastrectomy in Elderly Patients with Gastric Cancer

    • Katsunobu Sakurai
    • Tatsuro Tamura
    • Kosei Hirakawa

    Gastrointestinal Oncology 20 May 2016 Pages: 3669 - 3676

    

38. Early Gastric Cancer: Trends in Incidence, Management, and Survival in a Well-Defined French Population

    • Nicolas Chapelle
    • Anne-Marie Bouvier
    • Valerie Jooste

    Gastrointestinal Oncology 23 May 2016 Pages: 3677 - 3683

    

39. Biomarkers of EBV-positive Gastric Cancers: Loss of PTEN Expression is Associated with Poor Prognosis and Nodal Metastasis

    • Hyo Jeong Kang
    • In-Seob Lee
    • Byung-Sik Kim

    Gastrointestinal Oncology 24 May 2016 Pages: 3684 - 3692

    

40. Hepatic Resection for Metastatic Neuroendocrine Cancer in Patients with Bone Metastases

    • Kristopher P. Croome
    • Justin M. Burns
    • David M. Nagorney

    Gastrointestinal Oncology 17 May 2016 Pages: 3693 - 3698

    

41. Safety and Feasibility of Repeatable Hepatic Vascular Isolation Chemotherapy: A Pilot Study

    • Rodney J. Lane
    • Nyan Y. Khin
    • Stephen Clarke

    Hepatobiliary Tumors 25 March 2016 Pages: 3699 - 3708

    

42. Oncological Outcomes of Major Liver Resection Following Portal Vein Embolization: A Systematic Review and Meta-analysis

    • Mariano Cesare Giglio
    • Alexandros Giakoustidis
    • Long R. Jiao

    Hepatobiliary Tumors 08 June 2016 Pages: 3709 - 3717

    

43. Parenchymal-Sparing Hepatectomy Does Not Increase Intrahepatic Recurrence in Patients with Advanced Colorectal Liver Metastases

    • Masaru Matsumura
    • Yoshihiro Mise
    • Yu Takahashi

    Hepatobiliary Tumors 20 May 2016 Pages: 3718 - 3726

    

44. A Randomized Clinical Trial of Preoperative Administration of Branched-Chain Amino Acids to Prevent Postoperative Ascites in Patients with Liver Resection for Hepatocellular Carcinoma

    • Yutaro Kikuchi
    • Yukihiko Hiroshima
    • Kuniya Tanaka

    Hepatobiliary Tumors 23 June 2016 Pages: 3727 - 3735

    

45. Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location

    • Kazunari Sasaki
    • Georgios A. Margonis
    • Timothy M. Pawlik

    Hepatobiliary Tumors 28 June 2016 Pages: 3736 - 3743

    

46. Factors Impacting Use of Robotic Surgery for Treatment of Endometrial Cancer in the United States

    • Erin A. Blake
    • Jeanelle Sheeder
    • Michael S. Guy

    Gynecologic Oncology 12 May 2016 Pages: 3744 - 3748

47. Sentinel Node Mapping in Cervical and Endometrial Cancer: Indocyanine Green Versus Other Conventional Dyes—A Meta-Analysis

    • Ilary Ruscito
    • Maria Luisa Gasparri
    • Andrea Papadia

    Gynecologic Oncology 09 May 2016 Pages: 3749 - 3756

    

48. Modified Appleby Procedure for Pancreatic Adenocarcinoma: Does Improved Neoadjuvant Therapy Warrant Such an Aggressive Approach?

    • Niek A. Peters
    • Ammar A. Javed
    • Matthew J. Weiss

    Pancreatic Tumors 21 June 2016 Pages: 3757 - 3764

    

49. Feasibility and Outcomes of the Third or More Episodes of Sequential Microvascular Reconstruction for Recurrent or Second Primary Oral Cancer

    • Anaeze C. Offodile II
    • Kai-Ping Chang
    • Huang-Kai Kao

    Reconstructive Oncology 20 May 2016 Pages: 3765 - 3772